GIM
DXCM icon

Granahan Investment Management’s DexCom DXCM Stock Holding History

Granahan Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,798
Closed -$451K – 168
2024
Q4 		$451K Buy
5,798
+1,657
+40% +$123K 0.02% 168
2024
Q3 		$278K Buy
4,141
+1,183
+40% +$97.1K 0.01% 181
2024
Q2 		$335K Sell
2,958
-120
-4% -$15.2K 0.01% 176
2024
Q1 		$427K Sell
3,078
-358
-10% -$45K 0.02% 177
2023
Q4 		$426K Buy
+3,436
New +$351K 0.01% 176
2020
Q2 		– Sell
-21,860
Closed -$1.47M – 194
2020
Q1 		$1.47M Sell
21,860
-46,640
-68% -$2.9M 0.08% 149
2019
Q4 		$3.75M Sell
68,500
-22,500
-25% -$1.07M 0.17% 108
2019
Q3 		$3.4M Buy
91,000
+8,488
+10% +$330K 0.19% 109
2019
Q2 		$3.09M Buy
82,512
+26,348
+47% +$828K 0.15% 113
2019
Q1 		$1.67M Sell
56,164
-134,596
-71% -$4.73M 0.09% 158
2018
Q4 		$5.71M Buy
190,760
+4,376
+2% +$139K 0.4% 75
2018
Q3 		$6.67M Buy
186,384
+1,588
+0.9% +$49.2K 0.36% 86
2018
Q2 		$4.39M Buy
184,796
+62,208
+51% +$1.32M 0.26% 109
2018
Q1 		$2.27M Buy
122,588
+19,248
+19% +$285K 0.16% 144
2017
Q4 		$1.48M Sell
103,340
-58,864
-36% -$765K 0.12% 157
2017
Q3 		$1.98M Sell
162,204
-8,276
-5% -$146K 0.17% 139
2017
Q2 		$3.12M Sell
170,480
-59,328
-26% -$1.1M 0.29% 107
2017
Q1 		$4.87M Sell
229,808
-1,095,792
-83% -$21.4M 0.49% 75
2016
Q4 		$19.8M Buy
1,325,600
+465,200
+54% +$8.24M 0.68% 56
2016
Q3 		$18.9M Buy
860,400
+22,000
+3% +$490K 0.62% 64
2016
Q2 		$16.6M Sell
838,400
-105,200
-11% -$1.79M 0.61% 61
2016
Q1 		$16M Buy
+943,600
New +$15.8M 0.58% 61

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Granahan Investment Management's DXCM Position: Q1 2025 in Review

Granahan Investment Management sold out of DexCom (DXCM) in Q1 2025, closing a stake of 5,798 shares — an estimated $451K sold.

Granahan Investment Management first reported a position in DXCM in Q1 2016 and held it in 22 quarters. The position peaked at $19.8M in Q4 2016. 934 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Granahan Investment Management reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Granahan Investment Management sold 5,798 DexCom shares in Q1 2025, an estimated $451K.
  • Granahan Investment Management first reported a position in DexCom in Q1 2016 and held it in 22 quarters.
  • Granahan Investment Management's DexCom position peaked at $19.8M in Q4 2016.
  • 934 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Granahan Investment Management's 13F filing for Q1 2025, filed 15 May 2025.